Letters, Testimony & Comments

November 8, 2010
Re: Docket No. FDA-2010-D-0451: Draft Guidance for Industry on Suicidality: ProspectiveAssessment of Occurrence in Clinical Trials Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for...
November 1, 2010
Re: Docket No. Docket No. FDA-2010-N-0506, Request for Comments on the Food and Drug Administration Fiscal Year 2011-2015 Strategic Priorities Document Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug...
November 1, 2010
Re: Docket No. FDA-2010-D-0246: Draft Guidance for Industry on Residual Drug in Transdermal and Related Drug Delivery Systems Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the...
October 29, 2010
No. 2010-1406 UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT ——————————— THE ASSOCIATION FOR MOLECULAR PATHOLOGY, THE AMERICAN COLLEGE OF MEDICAL GENETICS, THE AMERICAN...
October 29, 2010
RE: Request for comments and information at Step 3 on the proposed draft Recommendations for the Labeling of Foods and Food Ingredients obtained through Certain Techniques of Genetic Modification/Genetic Engineering (ALINORM 10/33/22 paras.159 to...
October 29, 2010
Re: Docket No. FDA–2010–N–0437, Development and Distribution of Patient Medication Information for Prescription Drugs Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA...
October 29, 2010
BIO submitted comments on FDA’s "Development and Distribution of Patient Medication Information for Prescription Drugs." The comments elaborate on previous comments and further address the questions raised at the September 27-28...
October 24, 2010
Dear Governor Fortuño: In what is currently one of the worst economic recessions to be experienced in our lifetime, the life sciences industry, and the biotechnology sector in particular, is defying all odds – Biotechnology companies...
October 21, 2010
Dear President Obama: On behalf of the Biotechnology Industry Organization (BIO), Advanced Biofuels Association (ABFA), Algal Biomass Organization (ABO) and our over 100 advanced biofuels, renewable chemicals and biobased product member...
October 18, 2010
Dear Mr. Arny: U.S. farmers are concerned about the long-term sustainability of their farms and their place in society. For this reason, farmers will embrace an achievable roadmap for the environmental, social and economic aspects of...
October 14, 2010
October 14, 2010 To: Members of the Ad Hoc Open-ended Working Group on Access and Benefit-sharing of the Convention on Biological Diversity Cc: Convention on Biological Diversity Secretariat From: The Heads of Biotechnology...
October 14, 2010
District Court Ruling Exposes Biotechnology to Unprecedented Tort Liability. BIO disputes the District Court Ruling that exposes biotechnology companies to unprecedented tort liability for the development and sale of biotechnology products that are...
October 6, 2010
Dear Ms. Smith: Thank you for taking the time to meet with BIO members on September 8. The information that you and Mike Gregoire provided was very informative. As we mentioned to you and Mike at that meeting, BIO's member companies are...
October 4, 2010
Dear Ms. Blue: This letter is submitted by the Biotechnology Industry Organization (BIO) in response to the request for public comments regarding USTR’s annual Report on Sanitary and Phytosanitary (SPS) Measures. BIO represents more than 1...
October 4, 2010
      Product Launch Stewardship Introduction Through its advocacy efforts, BIO’s Food and Agriculture Section supports a regulatory framework that facilitates and enables the development and commercialization of...
October 4, 2010
Dear Secretary Vilsack: For the past 15 years, agricultural products derived from modern biotechnology have provided significant agronomic benefits to America's farmers. From increased yields, to reducing the impact of agriculture on the...
October 1, 2010
Comments to the International Trade Administration: Vaccine production and additional planning for future possible pandemic influenza Dear Mrs. Earley, The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment the...
October 1, 2010
The Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,100 members worldwide. Our mission is to be the champion of...
September 30, 2010
Dear Ms. Maloy, As President and CEO of the Biotechnology Industry Organization (BIO) and on behalf of our more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S....